Cargando…

Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer

PURPOSE: The tetraspanin CD151 acts as a promoter of metastasis and invasion in several tumors. However, the role of CD151 in human gastric cancer (HGC) remains unclear. METHODS: Twenty HGC specimens and matched nontumor samples, human gastric epithelial cells (HGEC), and four gastric cancer cell li...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yue-Ming, Zhang, Zhong-Wei, Liu, Qing-Meng, Sun, Yi-Feng, Yu, Ji-Ren, Xu, Wei-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606477/
https://www.ncbi.nlm.nih.gov/pubmed/23533596
http://dx.doi.org/10.1371/journal.pone.0058990
_version_ 1782264021122023424
author Yang, Yue-Ming
Zhang, Zhong-Wei
Liu, Qing-Meng
Sun, Yi-Feng
Yu, Ji-Ren
Xu, Wei-Xing
author_facet Yang, Yue-Ming
Zhang, Zhong-Wei
Liu, Qing-Meng
Sun, Yi-Feng
Yu, Ji-Ren
Xu, Wei-Xing
author_sort Yang, Yue-Ming
collection PubMed
description PURPOSE: The tetraspanin CD151 acts as a promoter of metastasis and invasion in several tumors. However, the role of CD151 in human gastric cancer (HGC) remains unclear. METHODS: Twenty HGC specimens and matched nontumor samples, human gastric epithelial cells (HGEC), and four gastric cancer cell lines were used to analyze CD151 expression. Short hairpin RNA-mediated downregulation of CD151 expression in HGC cells was performed to examine the role of CD151 in the proliferation and metastasis/invasion of HGC cells in vivo and in vitro. The relationship of CD151 with integrin α3 in HGC cells was investigated by silencing integrin α3 followed by co-immunoprecipitation and immunofluorescence staining. Finally, the prognostic value of CD151 and integrin α3 was evaluated by immunohistochemistry in tissue microarrays of 76 HGC patients. RESULTS: CD151 was expressed at higher levels in HGC tissues and HGC cells than in nontumor tissues and HGEC cells. Down-regulation of CD151 by vshRNA-CD151 impaired metastasis and invasion of HGC-27 cells, but did not affect cell proliferation. CD151 formed a complex with integrin α3 in HGC cells. CD151-cDNA transfection rescued the metastatic potential and invasiveness of HGC-27-vshCD151 cells, but not those of HGC-27-vshintegrin α3 cells in vitro. Clinically, CD151 overexpression was significantly correlated with high TNM stage, depth of invasion and positive lymph node involvement (p<0.05), and high levels of integrin α3 were associated with large tumor size, high TNM stage, depth of invasion and lymph node involvement (p<0.05). Importantly, the postoperative 5-year overall survival of patients with CD151(low) and/or integrin α3(low) was higher than that of patients with CD151(high) and/or integrin α3(high). CONCLUSION: CD151 is positively associated with the invasiveness of HGC, and CD151 or the combination of CD151 and integrin α3 is a novel marker for predicting the prognosis of HGC patients and may be potential therapeutic targets.
format Online
Article
Text
id pubmed-3606477
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36064772013-03-26 Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer Yang, Yue-Ming Zhang, Zhong-Wei Liu, Qing-Meng Sun, Yi-Feng Yu, Ji-Ren Xu, Wei-Xing PLoS One Research Article PURPOSE: The tetraspanin CD151 acts as a promoter of metastasis and invasion in several tumors. However, the role of CD151 in human gastric cancer (HGC) remains unclear. METHODS: Twenty HGC specimens and matched nontumor samples, human gastric epithelial cells (HGEC), and four gastric cancer cell lines were used to analyze CD151 expression. Short hairpin RNA-mediated downregulation of CD151 expression in HGC cells was performed to examine the role of CD151 in the proliferation and metastasis/invasion of HGC cells in vivo and in vitro. The relationship of CD151 with integrin α3 in HGC cells was investigated by silencing integrin α3 followed by co-immunoprecipitation and immunofluorescence staining. Finally, the prognostic value of CD151 and integrin α3 was evaluated by immunohistochemistry in tissue microarrays of 76 HGC patients. RESULTS: CD151 was expressed at higher levels in HGC tissues and HGC cells than in nontumor tissues and HGEC cells. Down-regulation of CD151 by vshRNA-CD151 impaired metastasis and invasion of HGC-27 cells, but did not affect cell proliferation. CD151 formed a complex with integrin α3 in HGC cells. CD151-cDNA transfection rescued the metastatic potential and invasiveness of HGC-27-vshCD151 cells, but not those of HGC-27-vshintegrin α3 cells in vitro. Clinically, CD151 overexpression was significantly correlated with high TNM stage, depth of invasion and positive lymph node involvement (p<0.05), and high levels of integrin α3 were associated with large tumor size, high TNM stage, depth of invasion and lymph node involvement (p<0.05). Importantly, the postoperative 5-year overall survival of patients with CD151(low) and/or integrin α3(low) was higher than that of patients with CD151(high) and/or integrin α3(high). CONCLUSION: CD151 is positively associated with the invasiveness of HGC, and CD151 or the combination of CD151 and integrin α3 is a novel marker for predicting the prognosis of HGC patients and may be potential therapeutic targets. Public Library of Science 2013-03-22 /pmc/articles/PMC3606477/ /pubmed/23533596 http://dx.doi.org/10.1371/journal.pone.0058990 Text en © 2013 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yang, Yue-Ming
Zhang, Zhong-Wei
Liu, Qing-Meng
Sun, Yi-Feng
Yu, Ji-Ren
Xu, Wei-Xing
Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
title Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
title_full Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
title_fullStr Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
title_full_unstemmed Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
title_short Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
title_sort overexpression of cd151 predicts prognosis in patients with resected gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606477/
https://www.ncbi.nlm.nih.gov/pubmed/23533596
http://dx.doi.org/10.1371/journal.pone.0058990
work_keys_str_mv AT yangyueming overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer
AT zhangzhongwei overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer
AT liuqingmeng overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer
AT sunyifeng overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer
AT yujiren overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer
AT xuweixing overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer